ARTICLES
60 Article(s)
1, 2, 3, 4, 5, 6 >> >|
Document(s)
Title
 
:  Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial
Grégoire Cormier;Benoit Le Goff;Emmanuelle Dernis;Philippe Goupille;Aleth Perdriger;Theo Rispens;David Ternant;Gilles Paintaud;Emilie Ducourau;Marine Samain;Fabienne Le Guilchard;Lucia Andras;Eric Lespessailles;Antoine Martin;Thomas Armingeat;Valérie Devauchelle-Pensec;Elisabeth Gervais;Annick de Vries;Eric Piver;Céline Desvignes;Hervé Watier;Denis Mulleman
ObjectivesAnti-drug antibodies (ADA) are responsible for decreased adalimumab efficacy in axial spondyloarthritis (SpA). We aimed to evaluate the ability of methotrexate (MTX) to decrease adalimumab immunisation.MethodsA total of 110 patients eligibl...
 
:  Exposure–Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis
Stéphane Paul;Hubert Marotte;Arthur Kavanaugh;Philippe Goupille;Tore K. Kvien;Marc deLongueville;Denis Mulleman;William J. Sandborn;Niels Vande Casteele
Anti‐tumor necrosis factor (anti‐TNF) drugs are often prescribed for the treatment of rheumatoid arthritis (RA) and other immune‐mediated inflammatory diseases. Although this treatment has been shown to be effective in many patients, up to 40% of pat...